{"id":556717,"date":"2026-06-10T12:30:00","date_gmt":"2026-06-10T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=556717"},"modified":"2026-06-10T14:30:39","modified_gmt":"2026-06-10T12:30:39","slug":"diagnosticos-moleculares-modernos-e-opcoes-de-terapia-direcionada","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/diagnosticos-moleculares-modernos-e-opcoes-de-terapia-direcionada\/","title":{"rendered":"Diagn\u00f3sticos moleculares modernos e op\u00e7\u00f5es de terapia direcionada"},"content":{"rendered":"\n

O colangiocarcinoma (CCA) \u00e9 um dos tumores mais agressivos do sistema hepatobiliar e, frequentemente, s\u00f3 \u00e9 diagnosticado numa fase avan\u00e7ada. Os avan\u00e7os no diagn\u00f3stico molecular e na terapia orientada est\u00e3o a abrir cada vez mais op\u00e7\u00f5es de tratamento personalizadas. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

O colangiocarcinoma (CCA) \u00e9 um dos tumores mais agressivos do sistema hepatobiliar e, frequentemente, s\u00f3 \u00e9 diagnosticado numa fase avan\u00e7ada. Os avan\u00e7os no diagn\u00f3stico molecular e na terapia orientada est\u00e3o……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":556721,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Colangiocarcinoma ","footnotes":""},"category":[11551,11521,11524,11407,11379],"tags":[92963,92943,92934,92949,25826,92918,92916,92946,92953,92936,33721,92961,92940,92911,92922,92959,92937,92920,92945,92931,92914,92928,92941,92926,92942,92951,92929,92957,15814,92923,92955,92967,92909,92898,11773,92947,92944,92965],"powerkit_post_featured":[],"class_list":["post-556717","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-estudos","category-formacao-continua","category-gastroenterologia-e-hepatologia","category-oncologia-pt-pt","tag-alteracoes-moleculares","tag-amplificacao-de-her2","tag-braf-v600e","tag-cca-extra-hepatico-her2-positivo","tag-colangiocarcinoma-pt-pt","tag-colangiocarcinoma-extra-hepatico","tag-colangiocarcinoma-intra-hepatico","tag-combinacao-de-dabrafenib-e-trametinib","tag-combinacoes-a-base-de-trastuzumab","tag-dabrafenib-trametinib","tag-diagnosticos-moleculares-pt-pt","tag-dmmr","tag-entrectinib","tag-estudo-fight-202","tag-estudo-foenix-cca2","tag-estudos-clinicos-colangiocarcinoma","tag-fusao-da-ntrk","tag-fusao-fgfr2","tag-fusoes-ntrk","tag-futibatinib","tag-inibidores-de-fgfr-aprovados-pemigatinib-e-futibatinib","tag-inibidores-do-fgfr","tag-inibidores-trk","tag-ivosidenib-terapeutica-eficaz-de-segunda-linha","tag-larotrectinib","tag-msi-h","tag-mutacao-idh1","tag-oncologia-personalizada","tag-pembrolizumab-pt-pt","tag-pemigatinib-em-doentes-pre-tratados-com-fusoes-de-fgfr2","tag-perfilagem-ngs","tag-prognostico-e-terapia","tag-sequenciacao-de-nova-geracao","tag-terapia-direcionada-para-her2","tag-terapia-orientada","tag-terapias-de-diagnostico-do-tumor-como-o-larotrectinib-ou-o-entrectinib","tag-tumores-com-mutacoes-braf-v600e","tag-tumour-board-suica","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-16 12:58:41","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":556713,"slug":"diagnosticos-moleculares-modernos-y-opciones-de-terapia-dirigida","post_title":"Diagn\u00f3sticos moleculares modernos y opciones de terapia dirigida","href":"https:\/\/medizinonline.com\/es\/diagnosticos-moleculares-modernos-y-opciones-de-terapia-dirigida\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=556717"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556717\/revisions"}],"predecessor-version":[{"id":556722,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556717\/revisions\/556722"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/556721"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=556717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=556717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=556717"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=556717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}